Literature DB >> 19149584

Prion protein functions and dysfunction in prion diseases.

Akikazu Sakudo1, Kazuyoshi Ikuta.   

Abstract

Prion diseases are zoonotic infectious diseases caused by infectious particles, termed prions. Main component of prions is presumably a misfolded, partially protease-resistant conformer (PrP(Sc)) of a normal cell surface protein, the cellular prion protein (PrP(C)), whose anti-oxidative role is presumed by studies using prion protein (PrP)-knockout mice and cell lines. Major common features of prion diseases are PrP(Sc) deposition, astrocytosis, and vacuolation, but the presence of these features and transmission route are dependent on the combination of prion strain and host species. Generally, prions replicate first in the lymphoreticular system, although the presence of PrP(Sc) within lymphoid tissues seems to be dependent on factors such as route of prion exposure or type of prion strain. After that, prions travel to the brain via neuronal pathways along peripheral nerves, where their conversion leads to the accumulation of PrP(Sc) and a deficiency of PrP(C), contributing etiologically to the death of neurons including apoptosis and autophagy. In this review, we provide an overview of current information on PrP(C) and PrP(Sc) as well as their involvement in the pathogenesis of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19149584     DOI: 10.2174/092986709787002673

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

Review 1.  Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases.

Authors:  M Gasperi; A E Castellano
Journal:  J Endocrinol Invest       Date:  2010-09       Impact factor: 4.256

2.  C-Abl tyrosine kinase mediates neurotoxic prion peptide-induced neuronal apoptosis via regulating mitochondrial homeostasis.

Authors:  Bo Pan; Lifeng Yang; Jin Wang; Yunsheng Wang; Jihong Wang; Xiangmei Zhou; Xiaomin Yin; Zhongqiu Zhang; Deming Zhao
Journal:  Mol Neurobiol       Date:  2014-02-08       Impact factor: 5.590

Review 3.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

4.  Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.

Authors:  Mira Polajnar; Slavko Ceru; Nataša Kopitar-Jerala; Eva Zerovnik
Journal:  Front Mol Neurosci       Date:  2012-08-24       Impact factor: 5.639

5.  The 5' flanking region and intron1 of the bovine prion protein gene (PRNP) are responsible for negative feedback regulation of the prion protein.

Authors:  Guangai Xue; Yoko Aida; Takashi Onodera; Akikazu Sakudo
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

6.  Neuroprotective effect of cellular prion protein (PrPC) is related with activation of alpha7 nicotinic acetylcholine receptor (α7nAchR)-mediated autophagy flux.

Authors:  Jae-Kyo Jeong; Sang-Youel Park
Journal:  Oncotarget       Date:  2015-09-22

7.  Discriminant analysis of prion sequences for prediction of susceptibility.

Authors:  Ji-Hae Lee; Se-Eun Bae; Sunghoon Jung; Insung Ahn; Hyeon Seok Son
Journal:  Exp Mol Med       Date:  2013-10-11       Impact factor: 8.718

8.  Gingerol prevents prion protein-mediated neuronal toxicity by regulating HIF prolyl hydroxylase 2 and prion protein.

Authors:  Yang-Gyu Park; Sang-Youel Park
Journal:  Int J Mol Med       Date:  2014-09-16       Impact factor: 4.101

Review 9.  Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP.

Authors:  Akikazu Sakudo; Takashi Onodera
Journal:  Front Cell Dev Biol       Date:  2015-01-15

10.  The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis.

Authors:  Mohadeseh Mehrabian; Dylan Brethour; Hansen Wang; Zhengrui Xi; Ekaterina Rogaeva; Gerold Schmitt-Ulms
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.